HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH/Prada

This article was originally published in The Rose Sheet

Executive Summary

Companies acquire 51% of Fendi in a deal valued at $900 mil., LVMH announces Oct. 12. It remains unclear how the deal will affect the Fendi U.S. fragrance license, which is held by New York City-based LPI. LVMH and Prada beat out Gucci in a bidding war not unlike the recent Gucci/LVMH battle for Sanofi Beaute, which eventually went to Gucci. The Fendi family will continue to "fulfill important roles within the group," as members retain the positions of president and general manager, LVMH said. The deal follows a recent LVMH shopping spree, during which the company picked up Hard Candy, Bliss and BeneFit

You may also be interested in...



LVMH acquires majority stake in Fendi

Prada will sell 25.5% stake in Fendi to LVMH to focus financial backing and development efforts on brands in which it owns "either all or a majority of share of capital," firms announce Nov. 24. Following the transaction, LVMH will control 51% of fashion brand, while Fendi family will remaining 49%. For now, existing fragrance license will be maintained by Sanofi Beaute, a division of Prada-owned Gucci. Prada and LVMH jointly acquired a majority shareholder status in Fendi in October 1999 (1"The Rose Sheet" Oct. 18, 1999, In Brief)...

LVMH acquires majority stake in Fendi

Prada will sell 25.5% stake in Fendi to LVMH to focus financial backing and development efforts on brands in which it owns "either all or a majority of share of capital," firms announce Nov. 24. Following the transaction, LVMH will control 51% of fashion brand, while Fendi family will remaining 49%. For now, existing fragrance license will be maintained by Sanofi Beaute, a division of Prada-owned Gucci. Prada and LVMH jointly acquired a majority shareholder status in Fendi in October 1999 (1"The Rose Sheet" Oct. 18, 1999, In Brief)...

Gucci Acquires $583.4 Mil. Sanofi Beauty Business From Artemis

Gucci is purchasing Sanofi Beaute from Artemis for $1 bil., giving the fashion house Yves Saint Laurent fragrances and cosmetics, Roger & Gallet, and fragrance licenses for Van Cleef & Arpels, Oscar de la Renta, Fendi and Krizia. Sanofi beauty sales total $583.4 mil.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel